University of Missouri-Columbia Program

Program Overview

The Hematology and Medical Oncology Fellowship at the University of Missouri-Columbia is designed to provide rigorous training in the fields of hematology and medical oncology. This three-year program follows ACGME accreditation standards and accepts three fellows each year through a competitive selection process. Trainees can anticipate a comprehensive educational experience within a prestigious institution equipped with cutting-edge facilities, particularly at the Ellis Fischel Cancer Center, which is a cornerstone of cancer care in the region 1.

Curriculum and Clinical Training

The fellowship entails a minimum of 18 months of clinical training, with at least six months focused on benign hematology. Fellows gain wide exposure to a diverse range of neoplastic and hematologic disorders while engaging in multiple clinical and research opportunities. The program is supported by a high patient volume from the Ellis Fischel Cancer Center, renowned for its innovative treatment options and research endeavors 1.

Training Sites

The primary training site is the Ellis Fischel Cancer Center, which is known for being the first state cancer center located west of the Mississippi. The new, eight-floor facility enhances patient care, with smart room technologies that integrate seamlessly with electronic medical records. Furthermore, the program includes specialized training at SSM Health St. Louis University for transplant-related experiences, with plans for a new transplant center in Columbia 1.

Research Opportunities

Fellows are encouraged to participate in various clinical and basic research programs. The University of Missouri's unique research initiatives extend to precision therapeutics, reflecting the rapidly evolving landscape of oncology treatments. The university is also home to a leading research reactor and multi-disciplinary laboratories fostering collaboration and innovation in cancer research 1.

Conferences and Educational Activities

The fellows partake in various conferences that enhance their learning experience. Weekly conferences include hematology/pathology discussions, multidisciplinary tumor boards, and core didactic lectures. Participation in national scientific meetings, such as those organized by the American Society of Clinical Oncology and the American Society of Hematology, is also expected, promoting continued professional development 2.

Competitiveness and Application Requirements

The program is highly competitive, attracting candidates from diverse backgrounds, including U.S. and international medical schools. Applicants require completion of a three-year U.S. residency program in Internal Medicine, along with three letters of recommendation. Specific application requirements and deadlines are provided in detail during the application period, typically between mid-July and mid-August 1.

Visa Sponsorship and Support

The program offers support for visa sponsorship for qualified international medical graduates (IMGs). The common types of visas that are sponsored include the J-1 visa for clinical and research training. The program values diversity and welcomes applications from international candidates, furthering the strength of its fellowship community 1.

Current Fellows

The program is currently home to a diverse cohort of fellows from varying backgrounds and training experiences, including graduates from institutions within the United States and abroad. This rich tapestry of experiences enhances collaboration and peer support among fellows throughout their training 3.

Virtual Tour

Prospective fellows can view a 360-degree virtual tour of training facilities, including the Ellis Fischel Cancer Center and the University Hospital, to gain a sense of the environment and resources available during their fellowship experience 4.